Prenatal Diagnostic Market Will Generate Record Revenue by 2029
Prenatal Diagnostic Market is anticipated to grow at a considerable CAGR of 12.9% during the forecast period. One of the factors that are fueling the market is the contribution of the university in research and development for the prenatal diagnostic and product portfolio expansion strategy adopted by market players are further fuiling the market growth. For instance,
OPKO health’s buyout US
Arisona- in August 2021, OPKO health’s inc. recently announced the buyout
of the US arisona centralized laboratory prenatal testing business from Roche
Holding AG. The buyout will help in the expansion of bio references noninvasive
prenatal screening, which is unable to accelerate high-quality testing that can
have favorable impacts on the medical care and outcomes of patients.
UC Davis adds two new prenatal
diagnostic centers – in February 2020, UC Davis Health has added two new
prenatal diagnostic centers (PDC) clinics in Sacremento and Stokton. The
purpose of the expansion was to provide pregnant women a comprehensive counseling,
genetic screening, and diagnostic testing for monitoring fetal anomalies such
as chorionic villus sampling (CVS) and amniocentesis.
Research support expansion of
insurance plan of non-invasive prenatal testing – the research conducted by the
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences,
presents first of its kind published an analysis of results from an agreement
between Illumina inc., and insurer Harvard Pilgrim Health Care to expand
insurance coverage of noninvasive prenatal test for pregnant women.
To Request a Sample of our Report on Prenatal Diagnostic
Market: https://www.omrglobal.com/request-sample/prenatal-diagnostic-market
Market Coverage
• The
market number available for – 2022-2030
• Base
year- 2022
• Forecast
period- 2022-2030
Segment Covered-
·
By Method
·
By Test type
·
By End-User
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Abbott,Eurofines Scientific,
Illumina’s , Myriad Genetics Inc., Quest Diagnostics Inco., Hologic Inc.,
Natera Inc. and others.
Prental Diagnostic Market Report by Segment
By Method
• Blood
• Urine
• Ultrasound
• Amniocentesis
• Others
(percutaneous umbilical blood sampling)
By Test Type
• Invasive
• Non-Invasive
By End-User
• Hospitals
• Speciality
Clincs
• Diagnostic
Centers
A
full Report of Prenatal Diagnostic Market is Available @ https://www.omrglobal.com/industry-reports/prenatal-diagnostic-market
Prenatal
Diagnostic Market Report Segment by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Company Profiles
·
Abbott Molecular
·
America Holdings
·
Angle Plc.
·
Ariosa Diagnostics
·
Eurofins NTD Inc.
·
GeneDx
·
Hologic Inc.,
·
Illumina, Inc
·
Laboratory Corp
·
Myriad Genetics Inc.,
·
Natera, Inc.
·
PerkinElmer, Inc.
·
Prenatal Paternities Inc
·
Quest Diagnostics
·
Ravgen, Counsyl, Inc
·
Ravgen, Inc.,
·
Sequenom Center for Molecular Medicine, LLC,
·
TrovaGene, Inc.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services. The
company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment